Predicting Emotion with Biosignals: A Comparison of Classification and Regression Models for Estimating Valence and Arousal Level Using Wearable Sensors.

This study aims to predict emotions using biosignals collected via wrist-worn sensor and evaluate the performance of different prediction models. Two dimensions of emotions were considered: valence and arousal. The data collected by the sensor were used in conjunction with target values obtained from questionnaires. A variety of classification and regression models were compared, including Long Short-Term Memory (LSTM) models. Additionally, the effects of different normalization methods and the impact of using different sensors were studied, and the way in which the results differed between the study subjects was analyzed. The results revealed that regression models generally performed better than classification models, with LSTM regression models achieving the best results. The normalization method called baseline reduction was found to be the most effective, and when used with an LSTM-based regression model it achieved high accuracy in detecting valence (mean square error = 0.43 and R2-score = 0.71) and arousal (mean square error = 0.59 and R2-score = 0.81). Moreover, it was found that even if all biosignals were not used in the training phase, reliable models could be obtained; in fact, for certain study subjects the best results were obtained using only a few of the sensors.

Data-Driven Identification of Long-Term Glycemia Clusters and Their Individualized Predictors in Finnish Patients with Type 2 Diabetes.

Purpose: To gain an understanding of the heterogeneous group of type 2 diabetes (T2D) patients, we aimed to identify patients with the homogenous long-term HbA1c trajectories and to predict the trajectory membership for each patient using explainable machine learning methods and different clinical-, treatment-, and socio-economic-related predictors. Patients and Methods: Electronic health records data covering primary and specialized healthcare on 9631 patients having T2D diagnosis were extracted from the North Karelia region, Finland. Six-year HbA1c trajectories were examined with growth mixture models. Linear discriminant analysis and neural networks were applied to predict the trajectory membership individually. Results: Three HbA1c trajectories were distinguished over six years: "stable, adequate" (86.5%), "improving, but inadequate" (7.3%), and "fluctuating, inadequate" (6.2%) glycemic control. Prior glucose levels, duration of T2D, use of insulin only, use of insulin together with some oral antidiabetic medications, and use of only metformin were the most important predictors for the long-term treatment balance. The prediction model had a balanced accuracy of 85% and a receiving operating characteristic area under the curve of 91%, indicating high performance. Moreover, the results based on SHAP (Shapley additive explanations) values show that it is possible to explain the outcomes of machine learning methods at the population and individual levels. Conclusion: Heterogeneity in long-term glycemic control can be predicted with confidence by utilizing information from previous HbA1c levels, fasting plasma glucose, duration of T2D, and use of antidiabetic medications. In future, the expected development of HbA1c could be predicted based on the patient's unique risk factors offering a practical tool for clinicians to support treatment planning.